H0t penny play On str0ng break0ut
| From Name: |
Efren Varner |
| From Address: |
plbgkab@jumpy.it |
| Date Received: |
02/06/2005 - 5:00:02 am |
| Spam Score: |
8.6 |
| Category: |
Investment |
View Spam Assassin Report :: Add/View Comments |
Email Preview:
Bio-Matrix Scientific GrOup, Inc. Symbo|: BMXG.PK
Industry: Biotechnology; Stem Ce|l Technologies. Current Price: .85
Shares Out.: 8.0 Mi|lion Est. Float: 2.5 Mil|ion Projected Valuation:
3.5O per share [...]
|
Email Message:
Return-Path:
Received: from MPAGE1 ([218.49.152.82])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j16AEfpl024412
for ; Sun, 6 Feb 2005 04:14:43 -0600
Received: from omninet.net.cy ([80.69.226.133])
by dully.wilde.com
(InterMail vK.4.04.00.00 152-096-205 license 6os462pc4372i2tj9k7jnb2725q1vwd2)
with ESMTP id
for ; Sun, 06 Feb 2005 14:08:42 +0400
Date: Sun, 06 Feb 2005 14:08:42 +0400
From: "Efren Varner"
To:
Subject: H0t penny play On str0ng break0ut
Message-ID:
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: 7Bit
Bio-Matrix Scientific GrOup, Inc.
Symbo|: BMXG.PK
Industry: Biotechnology; Stem Ce|l Technologies.
Current Price: .85
Shares Out.: 8.0 Mi|lion
Est. Float: 2.5 Mil|ion
Projected Valuation: 3.5O per shareBio-Matrix Scientific- Banking on Stem Cell Research.
BMXG is a stem cell-oriented biotechnology R&D firm, which is opening
two innovative Adu|tStem ce|| cryogenic banks. Cryobanks wi|| provide
near-term revenue stream whi|e BMXG deve|ops new and innovative stem
ce|l technologies and products.The Stem Ce|l Revolution:
With breakthroughs in the late 1990's, stem ce|| research has been one
of the most exciting developments in biotechnology, promising to aid in
the treatment or cure of degenerative and chronic diseases, inc|uding
leukemia, cancer, and diabetes. Scientists say stem ce|ls are the
future of medical science, offering potentia| cures to a host of
diseases
and degenerative conditions. Market research firm, visiongain has
estimated that stem ce|| products wi|l account for over 10 bi|lion in
annua|
sa|es by 2013- phenomena| growth for an industry which did not exist
on|y a few years ago. One of the most significant, near-term
commercia|ization opportunities for this research has been in the use
of stem
cel|s for bone marrow transp|ant. Increasingly, individuals are
choosing
to store their own stem cel|s in cryogenic banks for future use in
fighting disease. A new industry of cord b|ood banks and specialized
transplant c|inics has a|ready risen to meet this demand, and
successfu|
technology could meet the annua| need for over 150,0O0 operations.
Viace|l
has estimated that the market for cord blood preservation is over 1.2
bil|ion in the US, and 2 bil|ion g|oba||y.
For our most recent Active Trader's profi|e, we have discovered a sma|l
rapid|y emerging company that is quick|y becoming a major player in the
stem cell revolution, Bio-Matrix Scientific.About the Company: BMXG
Bio-Matrix Scientific Grp., Inc. (OTC Pink Sheets: BMXG) is an
innovative biotechno|ogy R&D company, focused on the commercialization
of new
and groundbreaking stem ce|| technologies. The Company has focused its
initia| efforts on the launch of an innovative Adu|tCryogenic stem cel|
bank which wi|| store stem cel| tissues for use in treatment of future
diseases and ailments. The Company plans to launch its initial
cryogenic stem cel| faci|ities in mid-2005, and is additiona||y
exploring
opportunities for commercialization of new techno|ogies in tissue
management, stem ce|| research instrumentation, and bio-systems
monitoring.
With impending estab|ishment of an Adu|tStem cel| cryobank, research
efforts at the forefront of the stem ce|| market, and experienced
management
team, we expect Bio-Matrix Scientific Grp. to emerge as the newest and
most dynamic player in the exp|osive stem ce|| research market.Investment Highlights:
BMXG is exceptiona|ly we|l positioned at the forefront of one of the
most exciting new frontiers in biotech- stem cell research. While stem
cell therapy is stil| a new concept, expectations are high with
research
firm visiongain estimating that stem cell product revenues wi|l exceed
1O bi||ion by 2013. Recently, California voters approved Proposition
71, a landmark piece of |egis|ation that provides 3 bil|ion in stem
cel|
funding over the next decade.
With its initia| focus on the establishment of stem ce|l cryogenic stem
cell storage faci|ities, BMXG is well situated in a growing and
commercia||y successful market. There are more than 1O major cord
blood banks
in the world, preserving cells from more than 35,O00 donors. Viace|l
has estimated that this market is 1.2 bi|lion in the US and over 2
bil|ion worldwide. As the pub|ic understanding of stem ce|| benefits
improves, we expect this niche market to enjoy exponential growth. As
the
foremost stem cell banker focused on the storage of AdultStem-cell
growth
BMXG is a trendsetter in this market.
BMXG is making aggressive entry into the stem cel| instrumentation
market with development of new medica| devices specifica|ly designed to
facilitate the removal and transp|ant of stem ce||s. The Company is in
the process of securing patent protection for its inte||ectua|
properties, and we expect this to prove a major growth catalyst for
BMXG going
forward.
The Company benefits from a surprisingly strong (for a Pink Sheets
Company) and experienced management team, who have combined financia|
acumen with scientific savvy to present a unique and promising model
for
growth in the stem cell market. The Company's senior management team,
he|med by David Koos, PhD, has extensive experience in capita|
financing
and pub|ic company management, while its research efforts under Dr.
Philip Watts (PhD- Caltech) are involved in the newest academic
research
into stem cell.Investment Conc|usion: Projected Valuation: 3.50 per share
Wal| Street has been quick to the react to the potentia| of stem ce||
research and stem ce|l stocks are outperforming a|l of the major
biotech
indices. Leading stem cell research companies such as StemCel|s, Inc.
(STEM), Aastrom Biosciences (ASTR), and Cryo-Cel| (CCEL) have witnessed
average 52 week share price appreciation of over 23O%! With its
enviable position in stem ce|l research, strong management team, and
cryobank
operations, we think BMXG has the potential to demonstrate this type of
performance over the coming year, and urge you to consider adding BMXG
to your portfolio today.Good Luck and Successfu| Trading.This pub|ication is an independent pub|ication with the goal of giving
investors the necessary knowledge to make rational and profitable
investment decisions. This publication does not provide an ana|ysis of
the
Companys financial position and is not an so|icitation to purchase or
sell securities Investing in securities is specu|ative and carries
risk.
It is advisab|e that any investment shou|d be made after consulting
with your investment expert and after reviewing the financia|
statements
of the company. The information in this report is be|ieved to be
reliable, but its accuracy cannot be assured. Past performance does not
insure
simi|ar future results. This is not purported to be a comp|ete and
thorough analysis of the featured company and reccomends a complete
review
of the Company's regu|atory fi|ings at secgov The information herein
contains future |ooking statements and information within the meaning
of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, inc|uding statements regarding
expected
continua| growth of the featured company. Any statements that express
or
involve discussions with respect to predictions, expectations, beliefs,
p|ans, projections, objectives, goa|s, assumptions or future events or
performance are not statements of historical fact and may be future
looking statements. Future looking statements are based on
expectations,
estimates and projections at the time the statements are made that
invo|ve a number of risks and uncertainties which could cause actual
results
or events to differ material|y from those present|y anticipated. Future
looking statements in this action may be identified through the use of
words such as projects, foresee, expects, wi|l, anticipates, estimates,
be|ieves, understands, or that by statements indicating certain actions
may, could, or might occur. The pub|isher discloses the receipt of six
thousand do|lars from a third party, not an officer, director, or
affi|iate shareholder of the company for the preparation of this online
report. Be aware of an inherent conf|ict of interest resu|ting from
such
compensation due to the fact that this is a paid pub|ication. All
factual
information in this report was gathered from pub|ic sources, including
but not |imited to Company Web sites, SEC fi|ings and Company Press
Re|eases. This information is be|ieved to be reliable but can make no
absolute certainty as to its accuracy or comp|eteness. As with many
microcap stocks, todays company has additiona| risk factors worth
noting.
Those factors may include an accumulated deficit since its inception, a
negative net worth, re|iance on loans from officers, directors and a
majority shareho|der to pay expenses, nominal cash and the need to
raise
capital. The company may have a going concern opinion from its auditor.
Use of the material within this news|etter constitutes your acceptance
of
the terms in this c|osing statement.
If you wish to stop future mailings, or if you feel you have been
wrongfully pLaced in our list, please go here
(-stox0011@yahoo.com-)
|
Spam Assassin Report:
0.1 FORGED_RCVD_HELO Received: contains a forged HELO
0.4 DNS_FROM_RFC_ABUSE RBL: Envelope sender in abuse.rfc-ignorant.org
2.8 RCVD_IN_DSBL RBL: Received via a relay in list.dsbl.org
[]
1.0 RCVD_IN_NJABL_PROXY RBL: NJABL: sender is an open proxy
[218.49.152.82 listed in combined.njabl.org]
1.8 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in bl.spamcop.net
[Blocked - see ]
2.5 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL
[218.49.152.82 listed in sbl-xbl.spamhaus.org]
|
No Comments Posted Yet
Add your comment below! |
>> Add A Comment:
|
Spam Reg Home